Lawsuit Alleges Companies
Sold Contaminated Blood Overseas June
(San Francisco-AP) -- Bayer
is defending itself against the claims of thousands of hemophiliacs,
who say Bayer knowingly sold them blood-clotting products
that were tainted with H-I-V and hepatitis C.
Sick hemophiliacs in countries outside the U-S sued Bayer
and other companies yesterday.
They claim the companies made products from the blood of
sick, high-risk donors, and distributed them abroad in 1984
and 1985. That was shortly after the companies stopped selling
them in the United States because of the known risk of H-I-V
and hepatitis transmission.
The medicine -- called Factor Eight concentrate -- can stop
or prevent potentially fatal bleeding in people with hemophilia.
Today Bayer rejected the accusations, saying it complied
with all regulations in the countries where it sent its products.